India: from generics giant to innovation powerhouse?
India’s pharma growth has been built on low-cost generics, making it the world’s 11th-largest market by value
Makary's successor faces tough task managing FDA amid budget cuts
For Marty Makary’s successor, the priority now is to keep a vital regulatory machine running
Trump's 100% pharma tariffs will have a limited effect on the sector
This new tariff appears driven by geopolitical considerations, limiting the economic impact
L'impatto dei farmaci per la perdita di peso sulla domanda alimentare in Europa è contenuto, ma le aziende dovranno adattarsi gradualmente al…
Europe's pharma industry can be a powerhouse again, but it needs to act fast
Pharma’s Godfather moment: pulled back into tariff uncertainty
Pharma's 2026 hit list: The White Album
Money (That's What I Want): 2026 is the year of truth for Trump’s…
La siccità del Reno mostra perché il commercio deve adattarsi al clima che…
Ora la siccità rallenta l’economia tedesca
Eurozona, giù le vendite al dettaglio: i consumi restano il punto debole
Pharma, l’Europa perde terreno, mentre la Cina innova più di tutti
Come Together: Pharma M&A set to accelerate in 2026
With a Little Help From My Friends: the importance of CDMOs will continue to…
Europa e USA dipendono dalla Cina per i farmaci generici: ma la sicurezza…
Webinar: the pharmaceutical industry's global reset
Is the global pharmaceutical industry entering a new era?
Accordo Pfizer-USA: così Trump aiuta le case farmaceutiche, ma non i pazienti
I benefici per i consumatori saranno modesti.
Dazi USA sul settore farmaceutico: ecco le nostre 4 previsioni
Usa, pillole amare per l’industria farmaceutica: i dazi di Trump frenano…
US drug prices and shortages set to rise despite Trump’s latest executive…
US consumers to be hit hardest by pharmaceutical tariffs
Trump set to break WTO rules with potential pharma tariffs
Sanità e farmaceutica, 5 cose da tenere d’occhio nel 2025
